CORC

在结果中检索

CORC

浏览/检索结果: 共70条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway 期刊论文
PHYTOMEDICINE, 2023, 卷号: 108
作者:  Hu, Yiqun;  Wen, Qingliang;  Cai, Yefeng;  Liu, Yunye;  Ma, Wenli
收藏  |  浏览/下载：238/0  |  提交时间：2022/12/23
Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition) 期刊论文
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 卷号: 16
作者:  Xu, Dong;  Ge, Minghua;  Yang, Ankui;  Cheng, Ruochuan;  Sun, Hui
收藏  |  浏览/下载：92/0  |  提交时间：2020/11/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：50/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Saliency-Guided Repetition Detection From Facade Point Clouds 期刊论文
2019, 卷号: 7, 页码: 150072-150081
作者:  Hao, Wen;  Liang, Wei;  Wang, Yinghui;  Zhao, Minghua;  Li, Ye
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/20
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial 期刊论文
2019, 卷号: 4, 期号: 5, 页码: 418-427
作者:  Wu, Yangfeng;  Li, Shenshen;  Patel, Anushka;  Li, Xian;  Du, Xin
收藏  |  浏览/下载：228/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace